Shanghai Pioneer Holding Ltd
HKSE: 1345.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Yuewen Yang
- Employees
- 335
- Headquarters
- Shanghai, China
- IPO year
- 2013
- Market cap
- HK$2.6B
- Website
- https://www.pioneer-pharma.com
Loading 1345…
Loading profile data…Frequently asked questions about 1345
What does Shanghai Pioneer Holding Ltd (1345.HK) do?
China Pioneer Pharma Holdings Limited, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. It has a portfolio of pharmaceutical products, such as ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other ther...
Where does 1345.HK trade?
Shanghai Pioneer Holding Ltd (1345.HK) trades on the Hong Kong Stock Exchange.
What sector is 1345.HK in?
Shanghai Pioneer Holding Ltd (1345.HK) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Shanghai Pioneer Holding Ltd?
Yuewen Yang is the chief executive officer of Shanghai Pioneer Holding Ltd (1345.HK).
Where is Shanghai Pioneer Holding Ltd headquartered?
Shanghai Pioneer Holding Ltd is headquartered in China.
Does 1345.HK pay a dividend?
Yes — Shanghai Pioneer Holding Ltd (1345.HK) paid a trailing twelve-month dividend of HKD 0.12 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1345.HK go public?
Shanghai Pioneer Holding Ltd (1345.HK) completed its initial public offering in 2013.